A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Ossium Health, Inc.
Sanguine Biosciences
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals
CTI BioPharma
LEO Pharma
Novartis
Cellerant Therapeutics
Mesoblast, Ltd.
Cellerant Therapeutics
Texas Oncology Cancer Center
Alaunos Therapeutics
Ortho Biotech Products, L.P.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Wyeth is now a wholly owned subsidiary of Pfizer